Articles with "solid organ" as a keyword



Photo from wikipedia

Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada.

Sign Up to like & get
recommendations!
Published in 2019 at "JAMA dermatology"

DOI: 10.1001/jamadermatol.2019.0692

Abstract: Importance Keratinocyte carcinoma (KC), also known as nonmelanoma skin cancer, is the most common malignancy after solid organ transplant. Epidemiologic data on posttransplant KC in North America are limited by a lack of KC capture… read more here.

Keywords: incidence; organ transplant; solid organ; risk factors ... See more keywords
Photo from wikipedia

Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA dermatology"

DOI: 10.1001/jamadermatol.2021.5853

Abstract: Importance We describe the first report to our knowledge of cutaneous and systemic pathogenicity of human polyomavirus 9 in solid organ transplant recipients. Objective Three solid organ transplant recipients developed a widespread, progressive, violaceous, and… read more here.

Keywords: polyomavirus; human polyomavirus; transplant recipients; organ transplant ... See more keywords
Photo from wikipedia

The clinical and pathological features of plasma cell myeloma post solid organ transplantation

Sign Up to like & get
recommendations!
Published in 2020 at "American Journal of Hematology"

DOI: 10.1002/ajh.25988

Abstract: Plasma cell neoplasms (PCNs), comprising plasma cell myelomas (PCMs) and plasmacytomas, which occur after solid organ transplantation, represent rare subtypes of monomorphic post‐transplant lymphoproliferative disorders (M‐PTLDs). Data regarding the clinical and pathological features of post‐transplant… read more here.

Keywords: solid organ; organ transplantation; plasma cell; post ... See more keywords
Photo from wikipedia

Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5394

Abstract: This study aimed to systematically characterize transplant rejection after immune checkpoint inhibitors (ICIs) initiation in solid organ transplant recipients (SOTRs). read more here.

Keywords: checkpoint inhibitors; immune checkpoint; rejection; transplant recipients ... See more keywords
Photo from wikipedia

Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in Finland

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Cancer"

DOI: 10.1002/ijc.33934

Abstract: Cancer is a significant cause of morbidity and mortality after solid organ transplantation (SOT) and related to lifelong immunosuppression. This retrospective registry study assessed for the first time in Finland population‐based cancer risk and cancer… read more here.

Keywords: sir; mortality solid; solid organ; mortality ... See more keywords
Photo from wikipedia

Are heart transplant recipients more at risk for anal squamous carcinoma than other solid organ transplant recipients?

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Cancer"

DOI: 10.1002/ijc.33994

Abstract: Dear Editor, Although anal squamous cancer (ASC) remains a relatively rare disease, the rate is increasing by about 2% per year. In the metaanalysis by Clifford et al the incidence rate (IR) for ASC in… read more here.

Keywords: transplantation; heart; transplant recipients; organ transplant ... See more keywords
Photo by impulsq from unsplash

De novo thyroid cancer following solid organ transplantation—A 25‐year experience at a high‐volume institution with a review of the literature

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.24495

Abstract: We investigated the rate, stage, and prognosis of thyroid cancer in patients after solid‐organ transplantations, and compared this to the general population. read more here.

Keywords: cancer following; following solid; solid organ; thyroid cancer ... See more keywords
Photo from wikipedia

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

Sign Up to like & get
recommendations!
Published in 2018 at "Liver Transplantation"

DOI: 10.1002/lt.25310

Abstract: De novo malignancies are one of the major late complications and causes of death after liver transplantation (LT). Using extensive data from the French national Agence de la Biomédecine database, the present study aimed to… read more here.

Keywords: risk; solid organ; study; novo malignancies ... See more keywords
Photo from wikipedia

Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation

Sign Up to like & get
recommendations!
Published in 2022 at "Pediatric Pulmonology"

DOI: 10.1002/ppul.26217

Abstract: We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated… read more here.

Keywords: organ transplantation; patients cystic; elexacaftor tezacaftor; tezacaftor ivacaftor ... See more keywords
Photo from wikipedia

Use of CFTR modulators in special populations, part 3: Solid organ transplant.

Sign Up to like & get
recommendations!
Published in 2023 at "Pediatric pulmonology"

DOI: 10.1002/ppul.26396

Abstract: BACKGROUND Solid organ transplant (SOT) recipients with cystic fibrosis (CF) may benefit from the pulmonary and extrapulmonary benefits associated with CF transmembrane conductance regulator modulators. Nevertheless, evolution of modulator safety and efficacy data prompts consideration.… read more here.

Keywords: modulator; lung; transplant recipients; organ transplant ... See more keywords
Photo from wikipedia

Malignancy: An Adverse Effect of Immunosuppression.

Sign Up to like & get
recommendations!
Published in 2021 at "Handbook of experimental pharmacology"

DOI: 10.1007/164_2021_554

Abstract: Benefits of solid organ transplantation in end stage organ diseases are indisputable. Malignancy is a feared complication of solid organ transplantation and is a leading cause of mortality in patients with organ transplantation. Iatrogenic immunosuppression… read more here.

Keywords: solid organ; malignancy adverse; organ transplantation; malignancy ... See more keywords